Silo Pharma, Inc. (NASDAQ:SILO) Short Interest Update

Silo Pharma, Inc. (NASDAQ:SILO) was the target of a large decrease in short interest in the month of February. As of February 28th, there was short interest totalling 130,600 shares, a decrease of 16.1% from the February 13th total of 155,700 shares. Based on an average daily volume of 2,910,000 shares, the days-to-cover ratio is presently 0.0 days. Currently, 3.0% of the company’s shares are short sold.

Silo Pharma Price Performance

NASDAQ:SILO opened at $1.35 on Tuesday. The company has a 50 day simple moving average of $1.57 and a two-hundred day simple moving average of $1.23. Silo Pharma has a fifty-two week low of $0.77 and a fifty-two week high of $4.50.

About Silo Pharma

Silo Pharma Inc operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems.